Kiromic Biopharma, Inc. Share-based Payment Arrangement, Expense
Kiromic Biopharma, Inc. reported Share-based Payment Arrangement, Expense of $18.20 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-05-13
- Kiromic Biopharma, Inc. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $18.20K.
- Kiromic Biopharma, Inc. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $77.00K, a 76.60% decline year-over-year.
- Kiromic Biopharma, Inc. share-based payment arrangement, expense for the quarter ending 2021-06-30 was $77.80K, a 82.44% decline year-over-year.
- Kiromic Biopharma, Inc. share-based payment arrangement, expense for the quarter ending 2020-09-30 was $329.00K.
| Period end | Share-based Payment Arrangement, Expense | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month |
|---|---|---|---|---|
| 2022-03-31 | $18.20K 10-Q · filed 2022-05-13 | |||
| 2021-09-30 | $77.00K 10-Q · filed 2022-03-11 | $154.80K derived: sum of 2 quarters · filed 2022-03-11 | $275.80K 10-Q · filed 2022-03-11 | |
| 2021-06-30 | $77.80K 10-Q · filed 2021-08-13 | $198.80K 10-Q · filed 2021-08-13 | ||
| 2020-09-30 | $329.00K 10-Q · filed 2022-03-11 | $772.00K derived: sum of 2 quarters · filed 2022-03-11 | $1.23M 10-Q · filed 2022-03-11 | |
| 2020-06-30 | $443.00K 10-Q · filed 2021-08-13 | $899.00K 10-Q · filed 2021-08-13 | ||
| 2020-06-08 | $9.43M 10-K · filed 2022-04-08 |